Skip to main content
. 2019 Feb 15;10:29–35. doi: 10.2147/VMRR.S186202

Table 2.

Comparison of biomarkers level of healthy dogs with and without astaxanthin supplementation

Parameter without ASX (n=5) with ASX (n=5)

0 week 6 weeks 0 week 6 weeks

Body weight (kg) 10.5 ± 0.2 11.3 ± 0.3 10.3 ± 0.2 11.1 ± 0.3
Body condition score 3 3 3 3
Glucose (mg/dL) 87.4 ± 1.8 79.8 ± 2.1 90.6 ± 2.5 87.4 ± 2.3
Triglyceride (mg/dL) 30.6 ± 1.3 38.0 ± 6.6 37.2 ± 1.3 23.6 ± 4.1 *
Total cholesterol (mg/dL) 144.8 ± 20.0 131.6 ± 8.9 113.8 ± 6.5 133.6 ± 9.1
NEFA (mEq/L) 0.7 ± 0.1 0.7 ± 0.1 0.8 ± 0.0 1.0 ± 0.1
Total protein (g/dL) 7.1 ± 0.1 7.0 ± 0.1 6.8 ± 0.1 6.6 ± 0.1
Blood urea nitrogen (mg/dL) 13.4 ± 0.7 12.0 ± 0.7 12.4 ± 0.7 10.2 ± 0.6
Creatinine (mg/dL) 0.7 ± 0.0 0.7 ± 0.0 0.7 ± 0.0 0.7 ± 0.1
Malondialdehyde (μ/mol/L) 1.5 ± 0.2 1.5 ± 0.1 1.5 ± 0.2 0.9 ± 0.0**,***
Insulin (ng/mL) 0.2 ± 0.0 0.3 ± 0.1 0.3 ± 0.1 0.3 ± 0.1
Adiponectin (μg/mL) 18.4 ± 4.0 27.5 ± 3.3 27.0 ± 6.3 30.5 ± 4.3
TNF-α (pg/mL) 0.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.0
AST (IU/L) 32.2 ± 1.8 35.2 ± 2.4 37.2 ± 1.3 33.6 ± 1.5
ALT (IU/L) 28.5 ± 4.1 30.2 ± 5.2 31.6 ± 1.2 36.4 ± 2.9
ALP (IU/L) 184.0 ± 46.3 166.6 ± 36.0 152.4 ± 8.7 152.6 ± 8.7
LDH (IU/L) 83.4 ± 5.7 113.6 ± 12.6 89.4 ± 6.3 57.4 ± 2.4**,***

Notes: Data are presented as the mean ± SE. Statistical significance is indicated by asterisks.

*

Significantly different (p<0.05) from the value at 0 week in the test group with ASX (paired t-test).

**

Significantly different (p<0.01) from the value at 0 week in the test group with ASX (paired t-test).

***

Significantly different (p<0.01) from the value at 6 weeks of the control group without ASX (paired t-test).

Abbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ASX, astaxanthin; LDH, lactate dehydrogenase; NEFA, non-esterified fatty acid; SE, standard error.SE, standard error.